Compare Bio Protocol (BIO) vs Cross The Ages (CTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Cross The Ages — how do they compare? Bio Protocol trades at Rp515.48 (market cap Rp1,16T, Rp252,63M 24h volume), while Cross The Ages trades at Rp13.91 (market cap Rp7,1M, Rp158,99jt 24h volume). The key difference: Bio Protocol is far larger — about 163380.3× Cross The Ages's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 500M / 500M CTA (100%) for Cross The Ages. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Cross The Ages for 7 Days on average.
| BIO | CTA | |
|---|---|---|
Market Cap | Rp1,16T | Rp7,1M |
Volume (24h) | Rp252,63M | Rp158,99jt |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 500M / 500M CTA (100%) |
Typical Hold Time | 16 Days | 7 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Cross The Ages (CTA) is currently trading at Rp15.244 with a market cap of Rp7.65 million, showing bearish technical signals with 17 sell signals versus 6 buy signals. The token trades near its pivot point of Rp16, with immediate support at Rp12 and resistance at Rp19. Despite the bearish moving averages, oscillators show some bullish divergence with RSI readings at extremely oversold levels of 2.23 (RSI_6) and 2.88 (RSI_12) as of current data.
The overall outlook remains cautious due to strong bearish momentum, though deeply oversold conditions suggest potential for near-term bounce. Key risks include low liquidity with only Rp7.65 million market cap and high volatility. Opportunities exist if the token can hold above Rp12 support and regain momentum toward Rp19 resistance level.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Cross The Ages
Cross The Ages (CTA) is a multimedia IP spanning video games, books, films, collectibles, and more, blending Web2 and Web3 ecosystems. It creates an expansive universe that engages its community through diverse experiences and entertainment.
Read more on CTA →
